Published in Gynecol Oncol on March 02, 2010
Extracellular signal-regulated kinase 8 (ERK8) controls estrogen-related receptor α (ERRα) cellular localization and inhibits its transcriptional activity. J Biol Chem (2010) 0.89
Risk-association of CYP11A1 polymorphisms and breast cancer among Han Chinese women in Southern China. Int J Mol Sci (2012) 0.80
No relationship between most polymorphisms of steroidogenic acute regulatory (StAR) gene with polycystic ovarian syndrome. Int J Reprod Biomed (Yazd) (2015) 0.76
CYP11A1 microsatellite (tttta)n polymorphism in PCOS women from South India. J Assist Reprod Genet (2014) 0.75
Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol (1995) 30.55
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03
Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered (2002) 8.64
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev (2002) 5.34
Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med (2000) 4.84
Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1998) 4.74
Hormonal carcinogenesis. Carcinogenesis (2000) 3.86
Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis (1998) 3.48
Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science (1995) 3.29
Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst (2004) 3.28
The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer (1988) 3.07
Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet (2009) 3.06
Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol (1996) 2.91
Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev (2000) 2.25
The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med (1996) 2.08
Buccal cell DNA yield, quality, and collection costs: comparison of methods for large-scale studies. Cancer Epidemiol Biomarkers Prev (2002) 1.92
A population-based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group. Cancer Epidemiol Biomarkers Prev (1996) 1.70
Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr (2000) 1.60
A case-control study of cancer of the endometrium. Am J Epidemiol (1982) 1.50
Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc Natl Acad Sci U S A (1997) 1.30
Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women. Int J Cancer (2002) 1.27
Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet (1997) 1.17
Variants in hormone biosynthesis genes and risk of endometrial cancer. Cancer Causes Control (2008) 1.14
Multiple displacement amplification prior to single nucleotide polymorphism genotyping in epidemiologic studies. Biotechnol Lett (2003) 1.11
Steroid deficiency syndromes in mice with targeted disruption of Cyp11a1. Mol Endocrinol (2002) 1.10
Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol (1983) 1.04
Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. J Clin Endocrinol Metab (2004) 1.01
Population-based case-control study of CYP11A gene polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2004) 1.01
Family history and the risk of endometrial cancer. Int J Cancer (1994) 0.97
Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol (1991) 0.96
A systematic assessment of common genetic variation in CYP11A and risk of breast cancer. Cancer Res (2006) 0.94
Androgen receptor polymorphisms and endometrial cancer risk. Int J Cancer (2006) 0.94
Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17alpha-hydroxylase/C(17-20) lyase promoters. Fertil Steril (2002) 0.91
Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome. Fertil Steril (2000) 0.89
Haplotype analysis of CYP11A1 identifies promoter variants associated with breast cancer risk. Cancer Res (2007) 0.89
Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women. Cancer Epidemiol Biomarkers Prev (2008) 0.86
Endometrial cancer as a familial tumor: pathology and molecular carcinogenesis (review). Curr Genomics (2009) 0.85
CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome. Fertil Steril (2008) 0.81
Postmenopausal unopposed estrogens. Characteristics of use in relation to the risk of endometrial carcinoma. Ann Epidemiol (1993) 0.80
Expression of enzyme associated with steroid hormone synthesis and local production of steroid hormone in endometrial carcinoma cells. J Endocrinol (2004) 0.80
Insulin resistance, polycystic ovary syndrome and metformin. Drugs (1999) 0.80
Effect of chronic estrogen treatment of Syrian hamsters on microsomal enzymes mediating formation of catecholestrogens and their redox cycling: implications for carcinogenesis. J Steroid Biochem (1990) 0.77
Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc (2007) 20.11
Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation (2007) 18.32
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc (2011) 14.42
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93
Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation (2011) 3.84
Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev (2007) 3.63
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 3.63
Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet Epidemiol (2005) 3.44
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 3.35
Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation (2007) 3.20
A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res (2007) 3.08
Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA (2006) 2.99
Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med (2007) 2.95
Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med (2008) 2.90
Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol (2002) 2.79
C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med (2005) 2.79
A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol (2008) 2.75
The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials (2011) 2.59
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Cost effectiveness of community-based physical activity interventions. Am J Prev Med (2008) 2.45
Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med (2012) 2.45
Migraine and coronary heart disease in women and men. Headache (2002) 2.44
Physical activity and cardiovascular health: lessons learned from epidemiological studies across age, gender, and race/ethnicity. Circulation (2010) 2.41
Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med (2013) 2.33
Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr (2010) 2.25
Associations between diet, lifestyle factors, and telomere length in women. Am J Clin Nutr (2010) 2.23
Lack of association between tea and cardiovascular disease in college alumni. Int J Epidemiol (2003) 2.23
C-reactive protein in the prediction of rheumatoid arthritis in women. Arch Intern Med (2006) 2.22
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell (2009) 2.22
Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study). J Am Coll Cardiol (2011) 2.20
Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum (2009) 2.19
Vitamin E and risk of type 2 diabetes in the women's health study randomized controlled trial. Diabetes (2006) 2.17
Egg consumption and risk of type 2 diabetes in men and women. Diabetes Care (2008) 2.14
Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men: the Aerobics Center Longitudinal Study. Circulation (2011) 2.13
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst (2011) 2.09
C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol (2004) 2.08
Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies. BMJ (2014) 2.06
Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension (2008) 2.04
Prescription of physical activity: an undervalued intervention. Lancet (2012) 2.03
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res (2013) 1.99
Alcohol consumption and breast cancer risk in the Women's Health Study. Am J Epidemiol (2007) 1.97
Recreational physical activity during pregnancy and risk of preeclampsia. Hypertension (2003) 1.93
Prospective study of gestational diabetes mellitus risk in relation to maternal recreational physical activity before and during pregnancy. Am J Epidemiol (2004) 1.92
C-reactive protein and risk of breast cancer. J Natl Cancer Inst (2007) 1.89
Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation (2006) 1.85
Physical activity and risk of stroke in women. Stroke (2010) 1.85
Alcohol consumption, weight gain, and risk of becoming overweight in middle-aged and older women. Arch Intern Med (2010) 1.85
Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst (2012) 1.82
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res (2007) 1.82
Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. J Natl Cancer Inst (2013) 1.80
A case-control study of maternal recreational physical activity and risk of gestational diabetes mellitus. Diabetes Res Clin Pract (2004) 1.79
Dichloroacetate induces apoptosis in endometrial cancer cells. Gynecol Oncol (2008) 1.79
A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer (2007) 1.76
Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med (2004) 1.76
A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst (2012) 1.74
Cardiorespiratory fitness and the incidence of type 2 diabetes: prospective study of Japanese men. Diabetes Care (2003) 1.72
Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation (2003) 1.71
A prospective study of cardiorespiratory fitness and risk of type 2 diabetes in women. Diabetes Care (2007) 1.71
Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev Res (Phila) (2011) 1.62
Telomere length and genetic analyses in population-based studies of endometrial cancer risk. Cancer (2010) 1.61
Sedentary behaviour and life expectancy in the USA: a cause-deleted life table analysis. BMJ Open (2012) 1.61
A tribute to Professor Jeremiah Morris: the man who invented the field of physical activity epidemiology. Ann Epidemiol (2010) 1.59
Is C-reactive protein specific for vascular disease in women? Ann Intern Med (2002) 1.54
A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev (2008) 1.53
The association of telomere length and genetic variation in telomere biology genes. Hum Mutat (2010) 1.53
Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004. Int J Cancer (2010) 1.52
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One (2008) 1.50
Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res (2011) 1.49
Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet (2002) 1.46
Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk. Cancer Res (2005) 1.45
Lifestyle interaction with fat mass and obesity-associated (FTO) genotype and risk of obesity in apparently healthy U.S. women. Diabetes Care (2011) 1.44
Adherence to physical activity guidelines in older adults, using objectively measured physical activity in a population-based study. BMC Public Health (2014) 1.44
Associations of cardiorespiratory fitness and obesity with risks of impaired fasting glucose and type 2 diabetes in men. Diabetes Care (2008) 1.43
Physical activity, sedentary behavior, and leukocyte telomere length in women. Am J Epidemiol (2012) 1.43
Development of a risk score for colorectal cancer in men. Am J Med (2007) 1.39
Genetic variants in telomere-maintaining genes and skin cancer risk. Hum Genet (2010) 1.38
Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. Mutat Res (2011) 1.37
Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.37
Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium. Cancer Epidemiol Biomarkers Prev (2009) 1.37
A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet (2011) 1.36
Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol (2005) 1.36
The joint effects of physical activity and body mass index on coronary heart disease risk in women. Arch Intern Med (2008) 1.35
Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol (2005) 1.35
Body mass index and mortality among US male physicians. Ann Epidemiol (2004) 1.35
Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet (2013) 1.34
Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res (2002) 1.33
Telomere length and risk of Parkinson's disease. Mov Disord (2008) 1.31
Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Hum Mol Genet (2012) 1.31